AzTrials
AzTrials

Vaginal DeliveryNCT06680804

Factors Affecting Success of Vaginal Birth After Cesarean Section

An observational study of Vaginal Delivery, run by Sohag University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Factors affecting Success of Vaginal Birth After Cesarean Section in Sohag University Hospitals Read more about this study

Who is it for?
Ages 20 to 40 years, women only
Conditions the study is for
Vaginal Delivery
What is being tested?
chance for vaginal delivery.
How many people
1 participants
Where
No sites listed yet
Study dates
1 Dec 2024to 1 May 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • Women only
  • Adult

Study population: All patients admitted for vaginal delivery with previous lower segment cesarean section . Age from 20 to 40 years.Time interval more than 1.5 years from previous caesarean section.

Who may be able to join

  • • Age from 20 to 40 years.
  • Time interval more than 1.5 years from previous caesarean section.
  • Single viable full-term pregnancy in vertex presentation.
  • Reactive cardiotocography (CTG) on admission.
  • Spontaneous labor onset.
  • Clinically adequate pelvis.
  • Single fetus
  • Average AFI fetus

Who cannot join

  • • Women with previous upper segment cesarean section or hysterotomy scar.
  • Any obstetric complications such as fetal malpresentation, placenta previa, or medical disorders like diabetes mellitus or preeclampsia.
  • Presence of any signs and symptoms of scar dehiscence or ruptured uterus, known uterine fibroid or anomaly.
  • Suspected fetal macrosomia (weight more than 4 kg).
  • Multifetal pregnancy.
  • Parturient women who refused the trial of vaginal birth after caesarean section.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Nahla Rashwan ezzeldine, master contact

01013774970

nashwa_rashwan_post@med.sohag.edu.eg

About this study

Official title: Factors Affecting Success of Vaginal Birth After Cesarean Section in Sohag University Hospitals

Factors affecting Success of Vaginal Birth After Cesarean Section in Sohag University Hospitals

Read the detailed description
  • Clinical data will be collected from the participants including demographic details such as age, maternal age, parity, BMI, gestational age based on last menstrual period or early ultrasound scans available.
  • Full medical and surgical history, previous CS details as an indication, and previous complications.
  • Patients' clinical abdominal and per vaginal examination on admission (cervical dilatation, effacement head station, and position).
  • CTG attached on admission (to exclude fetal distress).
  • Laboratory investigations that will be done before delivery and postpartum, Labor progress on the partogram will be assessed as regard duration of both first and second stages of labor if any instrumental delivery will be done.
  • Radiology investigations such as US.
  • Records for patients' vital signs, fetal cardiac activity during labor, vaginal bleeding, delivery notes, fetal weight, and 5 minutes APGAR score, and any recorded maternal or fetal complications.
  • If failed VBAC: Causes of failure maternal and fetal outcomes will be recorded and immediate CS to be done
Being tested
chance for vaginal delivery.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • chance for vaginal delivery.Other

    chance for vaginal delivery in patients who had delivered by Caesarean section in first pregnancy

Study groups in NCT06680804
Study groupRoleWhat they receive
Group I: Successful VBAC groupSuccessful VBAC group whose take chance for vaginal delivery.
Receives: Other: chance for vaginal delivery.
Group II: Failed VBAC groupFailed VBAC group whose take chance for vaginal delivery.
Receives: Other: chance for vaginal delivery.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. successful vaginal delivery

    successful vaginal delivery in patients who had delivered by Caesarean section in first pregnancy

    Measured: From November 2024 to April 2025

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Nov 2024
  2. Study start1 Dec 2024 (estimated)
  3. Primary completion1 May 2025 (estimated)
  4. Study completion1 May 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
1 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06680804
Sponsor's protocol ID
soh-Ned-15-10_9MS
Status last verified
Nov 2024
First submitted
7 Nov 2024
Last updated
8 Nov 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Vaginal Delivery, run by Sohag University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 8 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Nahla Rashwan ezzeldine, master (01013774970, nashwa_rashwan_post@med.sohag.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

successful vaginal delivery (time frame: From November 2024 to April 2025). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in